companydata.dkcompanydata.dk

ABBVIE A/S: Financial statements 2025

CVR: 34462828

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

ABBVIE A/S (CVR 34462828) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 472,957,984 and a net result of DKK 25,023,523 compared with DKK 11,055,919 the year before. That is an increase of 40.4% compared with the year before. The profit margin was 5.3%. Equity in the 2025 report amounted to DKK 98,011,918. The solvency ratio was 57.9%. The company had 55 employees in the financial year.

Revenue
DKK 472,957,984
Gross Profit
DKK 106,209,720
Profit/Loss
DKK 25,023,523
Equity
DKK 98,011,918
Total Assets
DKK 169,239,433
Employees
55

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025473M106.2M25M98M55
2024336.9M75.1M11.1M73M48
2023288.1M77.2M13.7M61.9M52
2022285M81.7M12.2M196.2M52
2021292.4M75M11.2M184M48

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ABBVIE A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

ABBVIE A/S wins public contractNov 14, 2025

ABBVIE A/S has won the tender "Amgros 2026 1.1060.a" issued by Amgros I/S worth 1,288,800,000 DKK.

ABBVIE A/S wins public contractOct 27, 2025

ABBVIE A/S has won the tender "Amgros 2026 1.1205.b" issued by Amgros I/S worth 497,443,398 DKK.

ABBVIE A/S wins public contractOct 7, 2025

ABBVIE A/S has won the tender "Amgros 2026 1.865.a" issued by Amgros I/S worth 1,570,800,000 DKK.

ABBVIE A/S wins public contractSep 29, 2025

ABBVIE A/S has won the tender "Amgros 2026 1.166.a" issued by Amgros I/S worth 804,000,000 DKK.

ABBVIE A/S wins public contractSep 24, 2025

ABBVIE A/S has won the tender "Amgros 2025 1.352.a" issued by Amgros I/S worth 157,080,000 DKK.

ABBVIE A/S: The 2024 annual report is outJun 26, 2025

ABBVIE A/S has published its annual report for 2024. Revenue came to DKK 336,906,684, and the net result was DKK 11,055,919.

ABBVIE A/S wins public contractApr 15, 2025

ABBVIE A/S has won the tender "Amgros 2025 1.1481.a" issued by Amgros I/S worth 44,800,000 DKK.

ABBVIE A/S wins public contractFeb 6, 2025

ABBVIE A/S has won the tender "Amgros 2025 1.350.a" issued by Amgros I/S worth 20,097,600,000 DKK.

About ABBVIE A/S

ABBVIE A/S is a Danish company of the type Aktieselskab based in København N, founded in 2012. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named WCA PHARMACEUTICALS A/S. The management consists of Thea Larsen. The board consists of Matthew Robert Iles (chair), Arnaud Jean Jacques Coint-Bavarot, Jens Lange and Shitra Irari Amozurrutia Blancas. The company is owned by AbbVie Central Finance B.V.. The company has 59 employees (2026). In 2025, the company reported revenue of DKK 472,957,984 and a net result of DKK 25,023,523 compared with DKK 11,055,919 the year before. Equity in the 2025 report amounted to DKK 98,011,918.

Source: annual report 2025, Danish Business Authority